General Practice · Avon, CT
NPI
1023253200
Since 2008
Specialty
General Practice
Code 208D00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
40 Dale Rd Ste 203
Avon, CT, 06001
Phone (631) 974-8826
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
159,343 services
Medicare patients, 2024
233
Average age 75
Drug cost, 2024
$5.2M
3,836 prescriptions
Company payments, 2025
$4,082
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yousong Wang was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 56,800 times for 15 patients. In total Yousong Wang billed 159,343 services in 34 codes, and Medicare paid $1.5M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-30.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 56,800 | 15 | $3.61 | $205K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 54,350 | 53 | $8.96 | $487K |
| J0897 Injection, denosumab, 1 mg | Office | 1,380 | 13 | $20.36 | $28K |
| 96365 Intravenous Infusion, Hydration | Office | 416 | 67 | $48.44 | $20K |
| 96372 Injection Administration | Office | 316 | 30 | $11.35 | $3,586 |
| 99214 Office E&M - Established | Office | 252 | 142 | $98.30 | $25K |
| 96413 Chemotherapy Administration | Office | 164 | 26 | $103.24 | $17K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 145 | 28 | $0.77 | $111 |
| 36415 Venipuncture Blood Collection | Office | 94 | 62 | $8.58 | $807 |
| 96415 Chemotherapy Administration | Office | 92 | 16 | $22.53 | $2,072 |
| 99204 Office E&M - New | Office | 31 | 31 | $130.43 | $4,043 |
| 20610 Joint Injection | Office | 20 | 14 | $64.23 | $1,285 |
| 99213 Office E&M - Established | Office | 19 | 19 | $75.56 | $1,436 |
By year: 2022 $2.0M for 141,458 services; 2023 $1.6M for 149,458 services; 2024 $1.5M for 159,343 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 94 | 62 | $8.58 | $807 |
Medicare prescription drug claims, 2024
In 2024, the drug Yousong Wang prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 761 prescriptions and refills. In total Yousong Wang wrote 3,836 Medicare prescriptions that cost $5.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 761 | 1,969 | 280 | $14K |
| Prednisone Generic | 670 | 1,444 | 256 | $4,404 |
| Hydroxychloroquine Sulfate Generic | 458 | 1,244 | 178 | $20K |
| Allopurinol Generic | 204 | 600 | 68 | $2,076 |
| Folic Acid Generic | 167 | 488 | 65 | $1,916 |
| Leflunomide Generic | 115 | 318 | 42 | $5,420 |
| Rinvoq Upadacitinib | 113 | 139 | 26 | $911K |
| Xeljanz Xr Tofacitinib Citrate | 105 | 107 | 15 | $632K |
| Enbrel Sureclick Etanercept | 100 | 109 | 19 | $798K |
| Tramadol Hcl Generic | 91 | 91 | 21 | $625 |
| Humira(Cf) Pen Adalimumab | 80 | 98 | 16 | $873K |
| Alendronate Sodium Generic | 58 | 140 | 17 | $344 |
| Gabapentin Generic | 58 | 115 | 19 | $561 |
| Colchicine Generic | 57 | 141 | 26 | $4,268 |
| Meloxicam Generic | 55 | 98 | 14 | $271 |
Brand drugs: - claims; generic drugs: 3,171 claims; opioid claims: 149.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yousong Wang $4,082 ($4,082 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $765.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 36 | $765 |
| Amgen Inc. AMGN | 27 | $693 |
| UCB, Inc. UCB.BR | 17 | $430 |
| E.R. Squibb & Sons, L.L.C. BMY | 9 | $293 |
| Novartis Pharmaceuticals Corporation NVS | 14 | $288 |
| AstraZeneca Pharmaceuticals LP AZN | 14 | $288 |
| GlaxoSmithKline, LLC. GSK | 10 | $240 |
| Pfizer Inc. PFE | 12 | $220 |
| Janssen Biotech, Inc. JNJ | 7 | $209 |
| Lilly USA, LLC LLY | 7 | $172 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.